UniProt ID | LGMN_HUMAN | |
---|---|---|
UniProt AC | Q99538 | |
Protein Name | Legumain | |
Gene Name | LGMN | |
Organism | Homo sapiens (Human). | |
Sequence Length | 433 | |
Subcellular Localization | Lysosome. | |
Protein Description | Has a strict specificity for hydrolysis of asparaginyl bonds. Can also cleave aspartyl bonds slowly, especially under acidic conditions. Required for normal lysosomal protein degradation in renal proximal tubules. Required for normal degradation of internalized EGFR. Plays a role in the regulation of cell proliferation via its role in EGFR degradation (By similarity). May be involved in the processing of proteins for MHC class II antigen presentation in the lysosomal/endosomal system.. | |
Protein Sequence | MVWKVAVFLSVALGIGAVPIDDPEDGGKHWVVIVAGSNGWYNYRHQADACHAYQIIHRNGIPDEQIVVMMYDDIAYSEDNPTPGIVINRPNGTDVYQGVPKDYTGEDVTPQNFLAVLRGDAEAVKGIGSGKVLKSGPQDHVFIYFTDHGSTGILVFPNEDLHVKDLNETIHYMYKHKMYRKMVFYIEACESGSMMNHLPDNINVYATTAANPRESSYACYYDEKRSTYLGDWYSVNWMEDSDVEDLTKETLHKQYHLVKSHTNTSHVMQYGNKTISTMKVMQFQGMKRKASSPVPLPPVTHLDLTPSPDVPLTIMKRKLMNTNDLEESRQLTEEIQRHLDARHLIEKSVRKIVSLLAASEAEVEQLLSERAPLTGHSCYPEALLHFRTHCFNWHSPTYEYALRHLYVLVNLCEKPYPLHRIKLSMDHVCLGHY | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
10 | O-linked_Glycosylation | WKVAVFLSVALGIGA HHHHHHHHHHHCCCC | 8.22 | 23301498 | |
91 | N-linked_Glycosylation | GIVINRPNGTDVYQG CEEEECCCCCCCCCC | 63.86 | 23776206 | |
125 | Ubiquitination | RGDAEAVKGIGSGKV HCCHHHHCCCCCCCE | 52.43 | 21906983 | |
125 | Ubiquitination | RGDAEAVKGIGSGKV HCCHHHHCCCCCCCE | 52.43 | 21906983 | |
129 | Phosphorylation | EAVKGIGSGKVLKSG HHHCCCCCCCEECCC | 33.26 | - | |
131 | Ubiquitination | VKGIGSGKVLKSGPQ HCCCCCCCEECCCCC | 46.20 | - | |
167 | N-linked_Glycosylation | DLHVKDLNETIHYMY CCCCCCHHHHHHHHH | 55.27 | 23776206 | |
185 | Phosphorylation | MYRKMVFYIEACESG HHHHEEEEEEECCCC | 6.09 | - | |
224 | Ubiquitination | YACYYDEKRSTYLGD CEEEEECCCCEECCC | 49.07 | - | |
224 | Ubiquitination | YACYYDEKRSTYLGD CEEEEECCCCEECCC | 49.07 | - | |
226 | Phosphorylation | CYYDEKRSTYLGDWY EEEECCCCEECCCCE | 32.26 | - | |
253 | Ubiquitination | LTKETLHKQYHLVKS HHHHHHHHHHCHHHC | 56.52 | - | |
263 | N-linked_Glycosylation | HLVKSHTNTSHVMQY CHHHCCCCCHHHHEE | 33.87 | 23776206 | |
272 | N-linked_Glycosylation | SHVMQYGNKTISTMK HHHHEECCEEEEHHH | 33.10 | 23776206 | |
274 | Phosphorylation | VMQYGNKTISTMKVM HHEECCEEEEHHHHH | 24.94 | - | |
276 | Phosphorylation | QYGNKTISTMKVMQF EECCEEEEHHHHHHH | 27.90 | - | |
277 | Phosphorylation | YGNKTISTMKVMQFQ ECCEEEEHHHHHHHC | 19.70 | - | |
287 | Acetylation | VMQFQGMKRKASSPV HHHHCCCCCCCCCCC | 58.53 | 11924495 | |
289 | Ubiquitination | QFQGMKRKASSPVPL HHCCCCCCCCCCCCC | 47.29 | - | |
305 | O-linked_Glycosylation | PVTHLDLTPSPDVPL CCCCCCCCCCCCCCH | 22.76 | OGP | |
307 | O-linked_Glycosylation | THLDLTPSPDVPLTI CCCCCCCCCCCCHHH | 28.62 | OGP | |
316 | Ubiquitination | DVPLTIMKRKLMNTN CCCHHHHHHCCCCCC | 42.40 | 21906983 | |
316 | Ubiquitination | DVPLTIMKRKLMNTN CCCHHHHHHCCCCCC | 42.40 | 21906983 | |
316 | 2-Hydroxyisobutyrylation | DVPLTIMKRKLMNTN CCCHHHHHHCCCCCC | 42.40 | - | |
318 | Ubiquitination | PLTIMKRKLMNTNDL CHHHHHHCCCCCCCH | 46.71 | 21906983 | |
318 | Ubiquitination | PLTIMKRKLMNTNDL CHHHHHHCCCCCCCH | 46.71 | 21906983 | |
322 | Phosphorylation | MKRKLMNTNDLEESR HHHCCCCCCCHHHHH | 19.02 | 30257219 | |
342 | Ubiquitination | IQRHLDARHLIEKSV HHHHHHHHHHHHHHH | 25.47 | - | |
347 | Ubiquitination | DARHLIEKSVRKIVS HHHHHHHHHHHHHHH | 47.45 | - | |
351 | Ubiquitination | LIEKSVRKIVSLLAA HHHHHHHHHHHHHHC | 45.35 | - | |
406 | Phosphorylation | EYALRHLYVLVNLCE HHHHHHHHHHHHHCC | 5.89 | 20068231 | |
414 | Ubiquitination | VLVNLCEKPYPLHRI HHHHHCCCCCCCCCE | 49.18 | - |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of LGMN_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of LGMN_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
TRAF6_HUMAN | TRAF6 | physical | 24610907 | |
U17L2_HUMAN | USP17L2 | physical | 24610907 | |
PDIA5_HUMAN | PDIA5 | physical | 26186194 | |
ATG7_HUMAN | ATG7 | physical | 26186194 | |
HNRH2_HUMAN | HNRNPH2 | physical | 26344197 | |
PDIA5_HUMAN | PDIA5 | physical | 28514442 | |
ATG7_HUMAN | ATG7 | physical | 28514442 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
N-linked Glycosylation | |
Reference | PubMed |
"Glycoproteomics analysis of human liver tissue by combination ofmultiple enzyme digestion and hydrazide chemistry."; Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.; J. Proteome Res. 8:651-661(2009). Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-91 AND ASN-167, AND MASSSPECTROMETRY. |